N/A
N=10
Temperature Profiles During Laser Activation in Ureteroscopic Lithotripsy
Ureteral Stone
Bottom Line
View on ClinicalTrials.gov: NCT05677425 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Temperature Profiles — 32.5; 35.3; 37.9; 40.0 Degrees Celcius
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Temperature measurement (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Haukeland University Hospital
- Primary completion
- Jun 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Temperature Profiles |
32.5; 35.3; 37.9; 40.0 | — |
Summary
The primary aim of this study is to investigate the temperature profiles in the renal pelvis during ureteroscopic Thulium Fiber Laser activation using different settings. To this end, comparison of peak temperatures during laser activation for different settings is the main aim. Secondary aim is trying to define the duration of safe laser activation until the threshold for heat induced cell injury (43oC) is reach.
Patients ≥ 18 years with a ureteral stone (with or without a concomitant renal stone) and an indwelling nephrostomy tube scheduled for ureteroscopic lithotripsy at the day surgery unit at Haukeland University Hospital, are eligible to enrolment in the study.
Temperature measurements during ureteroscopic laser stone disintegration will be performed. Follow-up is standardised with clinical consultation and low dose CT 3 months post endoscopically.
Eligibility Criteria
Inclusion Criteria
- Patients ≥ 18 years with a ureteral stone (with or without a concomitant renal stone) and an indwelling nephrostomy tube scheduled for URS lithotripsy at the Day Surgery unit at Haukeland University Hospital
Exclusion Criteria
- Urinary diversion
- Active infection
- Untreated cancer in the upper urinary tract
Data sourced from ClinicalTrials.gov (NCT05677425). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.